#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary haemorrhagic telangiectasia Arteriosclerosis Urethral valves Hypoparathyroidism Acute graft versus host disease Multiple system atrophy Growth hormone deficiency Philadelphia positive acute lymphocytic leukaemia Gastrooesophageal cancer Ependymoma Isodicentric chromosome 15 syndrome Mantle cell lymphoma Brain abscess IgA nephropathy Peripheral T-cell lymphoma unspecified More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Basic Information Hereditary ataxia – Life with Disease Pleomorphic leiomyosarcoma – Trials in Disease Mantle cell lymphoma stage III – Trials in Disease Lymphangioma – Basic Information Glomerulonephritis membranoproliferative – Life with Disease Marfan’s syndrome – Trials in Disease Rhabdoid tumour – Life with Disease Mastocytosis – Diagnostics Waldenstrom’s macroglobulinaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nitric Oxide Bisoprolol Fumarate Tng462 Tiratricol Amitriptyline 177LU-FAP-2286 Estradiol Valerate Enfuvirtide Sertraline 177Lu-Rhpsma-10.1 Diltiazem Hydrochloride Hydrochlorothiazide Dasatinib Valsartan GSK5458514 Calcipotriol Hydrocortisone Ph. Eur. Water For Injection BENZYDAMINE HYDROCHLORIDE Cdr132L More therapies…

    Learn about Your Condition

    Inflammation Post-traumatic headache Cholestatic pruritus Lymphangioma Metastases to peritoneum Infectious pleural effusion Juvenile absence epilepsy Seizure Iron overload Skin ulcer Lumbosacral radiculopathy Oedema Osteochondrodysplasia Malignant glioma Glomerulonephritis membranous More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Transitional cell carcinoma

  • Study on the Effectiveness and Safety of Tiragolumab, Atezolizumab, and Drug Combination for Patients with Urothelial Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Cisplatin
    • Gemcitabine Hydrochloride
    France Greece Spain

  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Metastatic malignant melanoma
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Alectinib
    • Alectinib Hydrochloride
    • Cobimetinib
    Belgium Czechia France Germany Greece Hungary +5

  • Study of Futibatinib and Pembrolizumab for Patients with Advanced or Metastatic Bladder, Urethra, or Pelvis Cancer Not Suitable for Platinum Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma recurrent
    • Transitional cell carcinoma
    Investigated Drugs:
    • Futibatinib
    • Pembrolizumab
    France

  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Incb099280
    Greece Hungary Romania

  • Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Nivolumab
    Austria Belgium Denmark France Germany Greece +7

  • Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Cervix carcinoma
    • Ovarian cancer
    Investigated Drugs:
    • Anhydrous Caffeine
    • Paracetamol Dc
    • Paracetamol Ph. Eur.
    Belgium France Poland Spain
Previous Page
1 … 5 6 7 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!